Evaluation of Next-Generation Software Features Using the Rhythmia Mapping System for Cardiac Arrhythmia Mapping

What this Trial Is About

Researchers are evaluating new software features designed to improve the Rhythmia Mapping System, a device used for electroanatomical mapping during catheter ablation procedures in patients with atrial or ventricular tachyarrhythmias. This observational study seeks to assess the performance of these next-generation software improvements by collecting and analyzing data during routine clinical care. The goal is to guide further development of the software features for future commercial use without affecting the current treatment. Participants undergo standard of care catheter-based endocardial mapping using the commercial Rhythmia Mapping System during their cardiac ablation procedures. While the procedure takes place, raw signals are streamed to an investigational Rhythmia Workstation running prototype software features. These new features are assessed in parallel but are not used by physicians to influence clinical decisions or treatment during the procedure. Throughout the study, participants receive their usual cardiac mapping and ablation care. Researchers collect feedback from physicians on the softwares performance during the procedure. Data from the investigational workstation is analyzed to evaluate the software without impacting patient care. The total participation duration aligns with the procedure day, and safety is maintained by not altering the clinical treatment process.

RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)